- States ranked by share of healthcare workers
- CMS finalizes framework for Medicaid work rules: 8 things to know
- Ochsner exec joins UMC New Orleans as COO
- Boston Children’s saves $7M, 60K hours with OpenAI
- From Calls to Clicks: Where Patient Experience Meets Throughput
- Maternal mental health grades by state
- 6 unique Rural Health Transformation fund proposals
- Illinois hospital taps CFO
- UHS Texas hospital taps new CFO
- Student debt rewrites oral surgery succession plans
- Health systems aren’t just killing more AI projects — they’re starting fewer
- Centerstone begins CEO transition
- 720 hospitals at risk of closure, by state
- Nonprofit opens dental center in Maine with $2M in funding
- 16 new behavioral health study findings to know
- AdventHealth relocates cardiology practice in Georgia
- Anesthesia under fire: 3 recent legal, policy fights
- Former lab CEO, physician to pay $1.2M+ to settle kickback scheme allegations
- MDMA-assisted therapy, explained
- PDS Health continues de novo growth with 5 new practices
- Commission Statement on the Passing of Former General Counsel David Becker
- 5 highest-paying states for specialty dentists
- Virginia oral surgery center opens 6th office
- New York health system to shutter ASC amid declining patient volume
- North Carolina projects $1B autism therapy spending: 6 notes
- 3 dental leadership moves to know
- CMS outlines national framework to support rollout of Medicaid work requirements
- The rise of the physician side hustle
- How NYU Langone is helping modernize a decades-old GI surgery tool
- The 6 highest-paying practice settings for ophthalmologists
- Dentists’ pay dipped the most in these 10 states
- Where the largest DSOs stand halfway through 2026
- ASCA elects new board president
- 7 physician practices shut their doors in 1 month
- Physician groups welcome IDR rule changes
- Indiana dental office suffers data breach affecting 5,900 individuals
- Your Surprise Medical Bill May Be Gone — But Your Premiums Could Still Spike
- New Connecticut private equity law bans hospital sale-leasebacks
- 17 dentists making headlines
- Mental health ED visits on the rise in 2026: 5 things to know
- How 4 systems are breaking the ED boarding cycle
- CDC: 2025's uninsured rate stayed flat at 8.3%
- Trump signs off on HHS overhaul of childhood vaccine schedule with new executive order
- Trump signs off on HHS overhaul of childhood vaccine schedule with new executive order
- Short-Term Fasting Could Boost Chemo Response in Ovarian Cancer, Study Suggests
- MedTech In Focus: AI impact in healthcare
- MedTech In Focus: AI impact in healthcare
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
- Patients with treatment-resistant depression are costing Medicare big
- Shionogi's COVID antiviral Xocova passes muster with FDA as post-exposure preventative
- How HER2 biology is shaping next-generation cancer treatment
- Workout Habits May Protect Against Inherited Heart Problems
- Childhood Lying Is Normal and Rarely Signals Behavioral Concerns, Study Says
- Perfectionism Among College Students Reaches Record High, Fueling Anxiety
- After Her Bout of Amnesia, A $59,000 Billing Dispute Wouldn't Go Away
- Weed Linked To Higher Testosterone Levels In Young Men
- Amid Ebola, Hantavirus Outbreaks, Democrats Decry Trump’s Health Cuts
- Baffling. Frustrating. Frightening. What It’s Like To Be Sued Over Medical Debt.
- Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight
- ViiV Healthcare launches ‘PrEP Wisdom’ campaign to boost awareness of long-acting HIV prevention meds
- Noom launches at-home biomarker test kit for metabolic health monitoring
- ASCO: AstraZeneca's Imfinzi, Imjudo duo shines in earlier-stage liver cancer
- CVS, Walgreens and Walmart defeat opioid lawsuit brought by Florida hospitals
- ASCO: Sac-TMT’s massive phase 3 program has a jarring gap. Does Merck plan to close it?
- ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34%
- ASCO: J&J breaks the prostate cancer treatment mold with fresh Erleada ph. 3 win
- ASCO: Revolution Medicines confident in RAS leadership as rivals square up
- Contraception For Teens: Let's Talk About It
- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: Lilly ties Retevmo to ‘dramatic’ outcomes in early-stage lung cancer with rare RET biomarker
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- Enzo Health launches agentic EHR for home health agencies
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Listen to the Latest ‘KFF Health News Minute’
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- Why direct-to-patient is the future of pharma access
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- Cleveland Clinic, Aspira Women’s Health partner on AI-powered women's health diagnostics
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Remarks at the Stanford Rock Center for Corporate Governance
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
Cui bono?
(Who benefits?) is not just for crime investigation! It's the #1 question to ask when the rules change for your healthcare or your license/workplace.
The Bureau of Professional Licensing (BPL) within the Department of Licensing and Regulatory Affairs (LARA) would like to inform you that the new Pharmacy Administrative Rules were effective as of February 29, 2024. A list of the notable changes is below. This is not intended to provide a comprehensive listing of all changes or current requirements. Licensees should review the rules and statute for a complete understanding of all applicable requirements.
The summary of changes is below:
For Pharmacy Services in Medical Institutions: Updates were made indicate that the limited number of medications may be stocked in patient care areas if pharmacist review and interpretation of the order before the administration of the first dose would adversely affect the patient’s medical condition.
For Pharmacist Licenses:
An individual participating in an unconventional internship is required to annually submit an affidavit from the internship supervisor including the type of activities performed and the number of hours completed.
A graduate from a program outside the United States may petition the board for approval of a maximum of 1,400 internship hours if the hours are not obtained through an approved educational program or under the personal charge of a Michigan-licensed pharmacist.
An internship preceptor is required to submit an affidavit including the number of internship hours completed by the intern in the practice of pharmacy, unless the hours are completed in an educational program.
The Multistate Pharmacy Jurisprudence Examination requirement is eliminated and replaced with an attestation that the applicant has sufficient knowledge of the Public Health Code and the Board of Pharmacy’s rules to competently practice pharmacy in Michigan.
For Pharmacy Licenses:If a pharmacist in charge (PIC) is unable to fulfil their duties for 120 consecutive days, the pharmacy shall appoint a new PIC and notify the department.
The 2023 revisions of USP Chapters 795 and 797 are adopted, with the exception of flavoring; inspection requirements are modified, including a 2-step inspection process for an in-state pharmacy that will compound sterile products and requiring out-of-state pharmacies that will not ship compounded sterile products into Michigan to submit inspections from their resident state boards of pharmacy or the National Association of Boards of Pharmacy (NABP) Verified Pharmacy Program.
Requirements for a pharmacy’s access to pharmacy laws and rules and reference texts are clarified.
A pharmacy that dispenses drugs is required to maintain a sink with running water, a refrigerator for the exclusive use of prescription drugs, and a telephone.
For Manufacturer Licenses:If a PIC or facility manager is unable to fulfil their duties for 120 consecutive days, the pharmacy shall appoint a new PIC or facility manager and notify the department.
Inspection and accreditation requirements were modified to provide the option of submitting an inspection from the United States Food and Drug Administration, the manufacturer’s resident state board of pharmacy, or NABP drug distributor accreditation.
For Wholesale Distributor and Wholesale Distributor-Broker Licenses:If a PIC or facility manager is unable to fulfil their duties for 120 consecutive days, the pharmacy shall appoint a new PIC or facility manager and notify the department.
For the Practice of Pharmacy:If a pharmacy intern completes final product verification under the supervision of a pharmacist, initials of both the pharmacy intern and the delegating pharmacist are required; modifies the locations where a pharmacy may operate an automated device; requires pharmacist review of orders and authorization of further dispensing within 48 hours when an automatic device is used as an after-hours cabinet, emergency kit, or when the system is accessed to treat the emergent needs of a patient;
The requirements for automated devices used in non-inpatient settings and in medical institutions were clarified.
A pharmacist may remotely access a pharmacy database as well as any other necessary databases that are routinely accessed to perform their functions and requires the pharmacist to provide adequate security.
The requirements for a pharmacist to dispense an emergency supply of insulin.
Please click HERE to view the revised Pharmacy rules.Our office is diligently working on updating relative information on our website to reflect the revisions of the revised rules. For more information, please visit our website at www.michigan.gov/bpl.
Please send questions about the revised rules to BPLHELP@michigan.gov.
More on the elimination of the Multistate Pharmacy Jurisprudence Examination requirement for pharmacist licenses:
Legal exam removed from pharmacist certification in Michigan
By Dustin Walsh - March 11, 2024It’s now easier to become a licensed pharmacist in the state of Michigan.
State regulators recently eliminated a widely used certification requirement by removing the Multistate Pharmacy Jurisprudence Exam, becoming only the second state in the U.S. to do so.
The jurisprudence exam is a 2.5-hour, 120-question multiple choice examination of federal and state laws formerly required in the state to become a certified pharmacist. Pharmacists are the only discipline in health care required to pass a law exam to receive licensure.
Experts are torn on whether removing the exam will jeopardize industry safety at a time when pharmacists are seeking more autonomy in the health care industry.
Keep up with all things West Michigan business. Sign up for our free newsletters today.
The elimination of the exam was quickly pushed through the Michigan Board of Pharmacy last summer in a controversial move and the new set of regulator rules was submitted to the Joint Committee on Administrative Rules in the legislature in July.
The committee finalized axing the exam on Feb. 29 and filed the rule change with the Secretary of State, making it official.
The elimination of the exam was supported by many in the industry, including national pharmacy chains and pharmacy benefits manager organizations.
During public comment last June, several individuals spoke in favor of getting rid of the exam. While none of the commenters disclosed their affiliations, at least one appeared to be a representative of a major insurer.
Jessica Morris, who according to her LinkedIn profile is a clinical consultant of strategic partnerships for Optum Inc., the pharmacy benefits subsidiary of UnitedHealth Group — the largest health insurer in the U.S. — called the exam “pointless” due to stopgap technology that ensures pharmacists follow all laws, state and federal.
But many pharmacists in the state disagreed with its removal, including the Michigan Pharmacists Association, who submitted complaints against the removal to the Joint Committee on Administrative Rules but were ultimately unsuccessful.
Eric Roath, director of government affairs for the industry group, questioned the wholesale removal of the exam from licensure in an interview with Crain’s last year.
“Pharmacists are far more likely to be brought before the pharmacy board for potential legal violations than any other provider,” Roath said. “Physician cases are usually due to a clinical error. Pharmacy is the highest-regulated field in health care. To say there are no better solutions to ensuring practice competency than to just remove the exam is wrong. The competency assessment is actually effective in verifying.”
Detractors say it’s likely chain pharmacies and multi-state health care providers favor eliminating the jurisprudence exams across the country in a bid to control their own costs and consolidate operations. Removing the exam could make it it easier for a consolidated pharmacy center in another state to fill scripts in Michigan, a move that could save millions of dollars.
Pharmacists are also one of the more prosecuted health care professions for violating laws.
A simple Google search of health insurance fraud by pharmacists in the region reveals more than a dozen indictments in the past five years that include distributing opioids to patients without a prescription to defrauding Medicare or Medicaid for reimbursement on drugs they didn’t prescribe or sold without a prescription.
In April last year, regulators in Idaho published a white paper in the American Journal of Pharmaceutical Education that stated there has been no evidence of public safety being jeopardized by its removal of the jurisprudence exam requirement. That article was co-written by Deeb Eid, who was listed as voluntary faculty at Ferris State University’s College of Pharmacy. His full-time job, though, is as a senior advisor of regulatory affairs for CVS.
It’ll likely take years to determine whether the removal of the MJPE impacts pharmacy operations or patient safety.
Great reporting!
Quite possibly the only deregulatory measure Michigan has taken, following Idaho or not.
Sure hope it doesn't offer the "bigs" an advantage over small start-ups. Finding out should be interesting.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















